The Source for Neurovascular News and Education

May 08, 2024

 

Key Points:

- Study compares clipping vs coiling of unruptured cerebral aneurysms in Medicare population

- Mortality and readmission rates similar for both, but longer hospital stay and more discharge to rehabilitation seen with clipping


Among elderly patients treated for unruptured cerebral aneurysms, clipping and coiling offer similar rates of readmission as well as of short- and long-term mortality, but clipping is associated with a higher rate of discharge to a rehabilitation facility and a longer length of stay. The findings were published online May 20, 2016, ahead of print in the Journal of Neurosurgery.

For the cohort study, Kimon Bekelis, MD, of Dartmouth-Hitchcock Medical Center (Lebanon, NH), and colleagues compared outcomes after treatment for unruptured cerebral aneurysms in elderly patients using 100% of Medicare fee-for-service claims data from 2007 to 2012.

“Propensity score stratification and [inverse probability weighting] were used to adjust our analyses for known confounders,” explained Dr. Bekelis in an email to Neurovascular Exchange. “The possibility of clustering, which can bias the results of multicenter national studies, was accounted for by using mixed effects methods. Most importantly, an [instrumental variable] analysis was used to control for unknown confounders and simulate the effects of randomization on treatment.”

Overall, 8,705 patients underwent treatment for unruptured cerebral aneurysms during the study period and met inclusion criteria. Of these, 2,585 (29.7%) had surgical clipping and 6,120 (70.3%) endovascular coiling.

There were no differences between the 2 therapies with regard to 30-day or 1-year postoperative mortality or the 90-day readmission rate. Clipping was associated, however, with a greater likelihood of discharge to rehabilitation and a longer length of stay (table 1)

 

Similar patterns were obtained with propensity score-adjusted and inverse probability-weighted models.


Methodological Limitations Addressed

“Our study purposefully addresses many of the methodological limitations of prior studies,” explained Dr. Bekelis. “First, we created a cohort of almost all elderly patients in the US, giving a true picture of national practice. Second, we used advanced observational techniques to control for confounding.” Instrumental variable analysis, for instance, helped balance out the fact that both aneurysm size and location influence treatment selection.

“In contrast to all prior studies, which lacked long-term survival results,” he continued, “we modeled our primary outcome as 1-year mortality to mimic the end point of ISAT. To identify the longitudinal effect of the treatment of unruptured aneurysms on outcomes, we also used time- to-event analyses.”

Dr. Bekelis explained that confirming these findings with a randomized trial would be problematic. “Our power analysis and the size of our study have demonstrated that attempting to identify a small mortality difference between the two techniques would [require an] impractically large [trial],” he said. “Alternatively, this question can be answered by the creation of large, long-term registries, and such efforts are underway.”

According to Dr. Bekelis, “Every aneurysm should be treated with the appropriate method as determined by the treating neurosurgeon, based on the patient characteristics and vascular anatomy.

“In recent years, the pendulum has swung dramatically in favor of coiling for unruptured aneurysms,” he acknowledged. “However, the comparative effectiveness of coiling and clipping in this population remains an issue of debate.”

 


Source:

Bekelis K, Gottlieb DJ, Su Y, et al. Comparison of clipping and coiling in elderly patients with unruptured cerebral aneurysms. J Neurosurg. 2016;Epub ahead of print.

Disclosures:

Dr. Bekelis reports no relevant conflicts of interest.

 

 

 

Monday, October 26 2020

Stroke rates for the balloon-expandable device far exceeded those of the Evolut R; conscious...

Read More »

Monday, October 26 2020

Safety goals were met in the trial, but better efficacy may require ensuring complete coverage of...

Read More »

Wednesday, September 23 2020

The findings “reinforce that this is absolutely the right thing to do and that we need to set up...

Read More »

Tuesday, July 21 2020

Whether COVID-19 adds risk by virtue of being a comorbidity or due to direct effects is unknown. A...

Read More »

Friday, May 8 2020

In some cases, large strokes are the first presentation of COVID-19 in younger patients, but...

Read More »

Monday, April 6 2020

Clopidogrel added to rivaroxaban and aspirin increased bleeding with no added protection from limb or...

Read More »

Monday, April 6 2020

Although rivaroxaban patients had more bleeding, the events were not severe and none were...

Read More »

Monday, April 6 2020

The strokes do not appear related to valve thrombosis or structural degeneration, but rather to...

Read More »

Thursday, January 23 2020

A fundamental unanswered question is whether any type of oral anticoagulation is needed in the...

Read More »

Monday, January 6 2020

Though periprocedural results look good, there are some questions about its rapid rise when...

Read More »

Wednesday, August 21 2019

In addition, an infarct in a new territory did not emerge as an independent predictor of...

Read More »

Wednesday, August 21 2019

The procedure—a hybrid of surgical and endovascular techniques—offers low stroke rates and a short...

Read More »